Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Activation of pDCs at the Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

NCT00960752 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00960752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00960752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Activation of pDCs at the Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
May 20, 2010
Completion date
July 20, 2020
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma